Follow The Filings

UPXI Upexi

Upexi earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 10 Nov EPS — — —
Rev — — —
FY2026 Q2 17 Sep EPS — -3.87 —
Rev $5.8M — —

Insider trades

Open-market buys and sales by UPXI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All UPXI insider trades
  • $1.1M bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Allan Marshall CEO
    Buy
    $90K 50,000 shares at $1.80 +1.3% to stake
    Traded Dec 23, 2025 Filed Dec 23, 2025
    ↗
  2. Allan Marshall CEO
    Buy
    $311K 150,000 shares at $2.07 +3.9% to stake
    Traded Dec 15–16 Filed Dec 17, 2025
    ↗
  3. Gene Salkind Director
    Buy
    $128K 50,000 shares at $2.55 +30% to stake
    Traded Nov 20, 2025 Filed Nov 21, 2025
    ↗
  4. Gene Salkind Director
    Buy
    $546K 200,000 shares at $2.73
    Traded Nov 17, 2025 Filed Nov 18, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 5 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEF 14A Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K FORM 10-K Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 3.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
424B3 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 3.01,8.01,9.01 Filing Doc
8-K 1.01,3.02,9.01 Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
DEF 14A Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.